Opiate reward: sites and substrates.

Area of Science:

• Neuroscience
• Pharmacology
• Addiction Research

Background:

• Opiates produce rewarding effects through actions in multiple brain regions.
• Dopaminergic systems are crucial for mediating the rewarding effects of intravenous heroin self-administration.
• Previous research has identified the ventral tegmental area (VTA) and nucleus accumbens (NAS) as key sites for opiate reward.

Purpose of the Study:

• To investigate the specific brain regions and neurochemical pathways involved in the rewarding actions of opiates.
• To determine the role of the dopaminergic system in mediating opiate-induced reward.
• To confirm and localize the sites of opiate rewarding actions within the brain.

Main Methods:

• Electrophysiological recordings and lesion studies targeting dopaminergic pathways.
• Behavioral assays including intravenous drug self-administration and conditioned place preference.
• Pharmacological manipulations involving dopamine receptor blockade and neuroleptics.
• Brain stimulation reward paradigms to assess the facilitation of reward.

Main Results:

• Intravenous heroin self-administration is dependent on a dopaminergic substrate.
• Morphine-conditioned place preference identifies the VTA as a site of rewarding action, dependent on dopamine.
• Opioid injections into the NAS facilitate brain stimulation reward and are rewarding themselves.
• Other suggested sites like the lateral hypothalamus and periaqueductal gray were not confirmed as localized opiate reward sites.

Conclusions:

• The ventral tegmental area (VTA) and nucleus accumbens (NAS) are firmly established as primary sites mediating the rewarding effects of opiates.
• Opiate reward in the VTA is dopamine-dependent, highlighting the interaction between opioid and dopamine systems.
• Further research is needed to clarify the role of other brain regions and specific opioid peptides, such as dynorphin in the hippocampus, in opiate reward and aversion.